Manuel Kadre
CIK 1396538 · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.36M
Companies
6
Total Filings
104
Lifetime Open-Market Net
$5.40M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RSG | Director | 4,245 | $209.59 | $889.7K | $0 | 62 | 2026-07-17 |
| HD | Director | 3,000 | $349.52 | $1.05M | $524.3K | 11 | 2026-05-26 |
| NeueHealth, Inc. (BHG) Delisted | Director | 0 | $16.35 | $0 | $3.66M | 12 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | Director | 33,506 | $6.75 | $226.3K | $0 | 2 | 2025-05-15 |
| MD | Director | 129,198 | $26.51 | $3.43M | $1.21M | 14 | 2021-05-14 |
| PDX | Director | — | $21.60 | — | $0 | 2 | 2008-05-23 |
Recent Filings · Page 3 of 11
104 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-17 | RSG | Grant (A) | — | $0 | EDGAR |
| 2023-07-18 | RSG | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | HD | Grant (A) | — | $0 | EDGAR |
| 2023-05-16 | NeueHealth, Inc. (BHG) Delisted | Mixed | +95,109 | $0 | EDGAR |
| 2023-04-17 | RSG | Grant (A) | — | $0 | EDGAR |
| 2023-01-17 | RSG | Grant (A) | — | $0 | EDGAR |
| 2023-01-04 | RSG | Grant (A) | — | $0 | EDGAR |
| 2022-12-16 | NeueHealth, Inc. (BHG) Delisted | Buy (P) | +185,000 | $120.2K | EDGAR |
| 2022-11-16 | NeueHealth, Inc. (BHG) Delisted | Buy (P) | +303,307 | $291.2K | EDGAR |
| 2022-11-14 | NeueHealth, Inc. (BHG) Delisted | Buy (P) | +296,693 | $293.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.